Home > Insider Trading > Ani Pharmaceuticals Inc > Profile

Ani Pharmaceuticals Inc (ANIP)

Market is closed

Sector: Pharmaceutical Preparations

Insider Roster

Chad Gassert, Svp - Corp. Dev. & Strategy, 2025-11-14
Meredith Cook, Sr. Vp, General Counsel & Sec., 2025-11-14
Krista Davis, Svp, Chief Hr Officer, 2025-09-22

Chad Gassert, Svp - Corp. Dev. & Strategy, 2025-11-14
Meredith Cook, Sr. Vp, General Counsel & Sec., 2025-11-14
Krista Davis, Svp, Chief Hr Officer, 2025-09-22
R Antonio Pera, Director, 2025-09-04
J Matthew Leonard, Director, 2025-08-26
Muthusamy Shanmugam, Head Of R&D, Coo-Novitium Ops, 2025-08-22
Jeanne Thoma, Director, 2025-08-20
D Patrick Walsh, Director, 2025-08-18
Andrew Thomas Rowland, Svp, Head - Established Brands, 2025-08-14
Nikhil Lalwani, President & Ceo, 2025-08-14
Ori Gutwerg, Svp, Generics, 2025-08-14
P. Stephen Carey, Svp & Cfo, 2025-08-14
Thomas Haughey, Director, 2025-08-14
P Renee Tannenbaum, Director, 2025-05-27
Christopher Mutz, Head Of Rare Disease, 2025-05-16
G. James Marken, Svp Ops & Prod Dev, 2024-06-11
Meridian Venture Partners Ii Lp, Large Shareholder, 2023-08-17
Meridian Venture Partners Ii Gp, L.p., Large Shareholder, 2023-08-17
Meridian Venture Partners Ii, Co., Large Shareholder, 2023-08-17
Jr E. Robert Brown, Large Shareholder, 2023-08-17
David Nash, Director, 2023-05-24
W Robert Schrepfer, Svp - New Bus Dev & Spec Sales, 2021-03-30
Arthur Przybyl, President and Ceo, 2020-04-08
A. Thomas Penn, Director, 2019-04-01
Tracy Marshbanks, Director, 2018-05-16
Fred Holubow, Director, 2018-03-22
Daniel Raynor, Director, 2018-03-19
C. Charlotte Arnold, Vice President and Cfo, 2016-04-11
A Peter Lankau, Director, 2016-04-11
J Ross Mangano, Director, 2014-09-16
J. Robert Jamnick, Vp, Quality & Product Develop., 2014-05-27
W Louis Sullivan, Director, 2012-03-30
Jr T John Potts, Director, 2012-03-30
Iii C Edward Rosenow, Director, 2012-03-30
A Stephen Sherwin, Director, 2012-03-30
C Michael Snabes, Sr. Vp Of Medical Affairs, 2012-01-27
B Philip Donenberg, Sr Vp Of Finance, Cfo, Secy, 2012-01-27
M Stephen Simes, Vice Chairman, President & Ceo, 2012-01-27
Peter Kjaer, Director, 2010-04-02

Show All Insiders (39)

Hedge Fund Popularity

Display

Display Share Price

Display Large Version

Hedge Fund Holdings

Filing Period:

Last updated on November 14, 2025, 5:07pm based on SEC 13F filings Last update: November 14, 2025, 5:07pm

No.	Hedge Fund	Shares	Value	Activity	% Port
1.	Citadel Investment Group Ken Griffin	580,085	$53,135,786	+2%	0.01%
2.	Deep Track Capital David Kroin	450,000	$41,220,000	-36%	1.15%
3.	Point72 Asset Management Steve Cohen	399,092	$36,556,814		0.06%
4.	HBK InvestmentsNOTE 2.250% 9/0 David Costen Haley	25,150,000	$35,339,581		0.39%
5.	Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell	360,178	$32,992,305		0.02%

Insider Trading: Purchases See All

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Lalwani	$27.69	7,224	$199,997.16	169,650	2022-03-21	Filing
Walsh	$27.76	5,000	$138,794.00	53,388	2022-03-21	Filing
Gassert	$27.87	5,000	$139,342.50	393,226	2022-03-21	Filing
Gassert	$27.15	5,000	$135,744.00	388,226	2022-03-18	Filing
Shanmugam	$27.65	5,000	$138,251.50	5,000	2022-03-17	Filing

Insider Trading: Sales See All

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Gassert Officer	$88.00	94	$8,272.00	158,490	2025-11-13	Filing
Gassert Officer	$89.07	14,642	$1,304,162.94	158,584	2025-11-12	Filing
Cook Officer	$87.27	400	$34,908.00	75,274	2025-11-13	Filing
Cook Officer	$90.09	400	$36,036.00	75,674	2025-10-13	Filing
Davis Officer	$98.04	1,000	$98,040.00	60,186	2025-09-19	Filing

Institutional Investors' Holdings

Filing Period:

No.	Name	Shares	Value	% Port
1.	Blackrock, Inc.	2,548,892	$233,478,507	0%
2.	Vanguard Group Inc	1,277,470	$117,016,252	0%
3.	Linden Advisors LpBOND	71,000,000	$99,829,421	0.67%
4.	State Street Corp	711,708	$65,192,453	0%
5.	Global Alpha Capital Management Ltd.	630,590	$57,762,044	3.3%

News See All

Click here to See All News